Here's Why You Should Retain PDCO Stock in Your Portfolio for Now - Quest Diagnostics ( NYSE:DGX ) , DaVita ( NYSE:DVA )
Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further.
| Ticker |
Sentiment |
Impact |
|
DGX
|
Somewhat Bullish
|
16 %
|
|
PDCO
|
Bullish
|
57 %
|
|
BSX
|
Neutral
|
8 %
|
|
DVA
|
Neutral
|
12 %
|
